Skip to main content Accessibility help
×
Home

Repeated and long-term treatment with physiological concentrations of resveratrol promotes NO production in vascular endothelial cells

  • Satoru Takahashi (a1) (a2) and Yukiko Nakashima (a2)

Abstract

In the present study, we examined the effect of repeated and long-term treatment with resveratrol on NO production in endothelial cells as a model of routine wine consumption. Repeated treatment with resveratrol for 5 d resulted in an increase in endothelial NO synthase (eNOS) protein content and NO production in human umbilical vein endothelial cell (HUVEC) in a concentration-dependent manner. A significant increase in functional eNOS protein content was observed with resveratrol, even at 50 nm. In contrast, eNOS phosphorylation was not stimulated and inducible NO synthase (iNOS) was not detected after resveratrol treatment. Both eNOS protein and mRNA expression were promoted by 50 nm-resveratrol in a time-dependent manner. Increased eNOS mRNA expression in response to resveratrol was not decreased by an oestrogen receptor (ER) antagonist ICI182780, a PPARα inhibitor MK886 or a sirtuin inhibitor Salermide. However, a combination of ICI182780 and MK886 significantly inhibited resveratrol-induced eNOS mRNA expression. Salermide had no effect even in the presence of ICI182780 or MK886. These results demonstrate that resveratrol within the physiological range increases eNOS mRNA and protein expression through ER and PPARα activation, thereby promoting NO production in endothelial cells. eNOS induction might result from the accumulative effect of nanomolar concentrations of resveratrol. The present study results can account in part for the observation that cardiovascular benefits of red wine are experienced with routine consumption, but not with acute consumption.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Repeated and long-term treatment with physiological concentrations of resveratrol promotes NO production in vascular endothelial cells
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Repeated and long-term treatment with physiological concentrations of resveratrol promotes NO production in vascular endothelial cells
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Repeated and long-term treatment with physiological concentrations of resveratrol promotes NO production in vascular endothelial cells
      Available formats
      ×

Copyright

Corresponding author

*Corresponding author: Dr S. Takahashi, fax +81 798 41 2792, email imwalrus@mukogawa-u.ac.jp

References

Hide All
1 Stoclet, J-C, Chataigneau, T, Ndiaye, M, et al. (2004) Vascular protection by dietary polyphenols. Eur J Pharmacol 500, 299313.
2 Cordova, AC, Jackson, LSM, Berke-Schlessel, DW, et al. (2005) The cardiovascular protective effect of red wine. J Am Coll Surg 200, 428439.
3 Opie, LH & Lecour, S (2007) The red wine hypothesis: from concepts to protective signalling molecules. Eur Heart J 28, 16831693.
4 Sato, M, Maulik, N & Das, DK (2002) Cardioprotection with alcohol: role of both alcohol and polyphenolic antioxidants. Ann N Y Acad Sci 957, 122135.
5 Dudzinski, DM, Igarashi, J, Greif, D, et al. (2006) The regulation and pharmacology of endothelial nitric oxide synthase. Ann Rev Pharmacol Toxicol 46, 235276.
6 Hattori, R, Otani, H, Maulik, N, et al. (2002) Pharmacological preconditioning with resveratrol: role of nitric oxide. Am J Physiol 282, H1988H1995.
7 Zou, JG, Wang, ZR, Huang, YZ, et al. (2003) Effect of red wine and wine polyphenol resveratrol on endothelial function in hypercholesterolemic rabbits. Int J Mol Med 11, 317320.
8 Miatello, R, Vázquez, M, Renna, N, et al. (2005) Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats. Am J Hypertens 18, 864870.
9 Zhang, H, Morgan, B, Potter, B, et al. (2010) Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging. Am J Physiol 299, H985H994.
10 Xia, N, Daiber, A, Habermeier, A, et al. (2010) Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apoprotein E knockout mice. J Pharmacol Exp Ther 335, 149154.
11 Wallerath, T, Deckert, G, Ternes, T, et al. (2002) Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106, 16521658.
12 Goldberg, DM, Yan, J & Soleas, GJ (2003) Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem 36, 7987.
13 Walle, T, Hsieh, F, DeLegge, MH, et al. (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32, 13771382.
14 Takahashi, S, Uchiyama, T & Toda, K (2009) Differential effect of resveratrol on nitric oxide production in endothelial F-2 cells. Biol Pharm Bull 32, 18401843.
15 Scifo, C, Cardile, V, Russo, A, et al. (2004) Resveratrol and propolis as necrosis and apoptosis inducers in human prostate carcinoma cells. Oncol Res 14, 415426.
16 Nicholson, SK, Tucker, GA & Brameld, JM (2010) Physiological concentrations of dietary polyphenols regulate vascular endothelial cell expression of genes important in cardiovascular health. Br J Nutr 103, 13981403.
17 Takahashi, S & Mendelsohn, ME (2003) Synergistic activation of endothelial nitric-oxide synthase (eNOS) by HSP90 and Akt. J Biol Chem 278, 3082130827.
18 Jones, R, Baker, MB, Weber, M, et al. (2009) Molecular beacons can assess changes in expression and 3′-polyadenylation of human eNOS mRNA. Am J Physiol 296, C498C504.
19 Fulton, D, Gratton, JP, MaCabe, TJ, et al. (1999) Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399, 597601.
20 Dimmeler, S, Fleming, I, Fisslthaler, B, et al. (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399, 601605.
21 Gehm, BD, McAndrews, JM, Chien, PY, et al. (1997) Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci U S A 94, 1413814143.
22 Bowers, JL, Tyulmenkov, VV, Jernigan, SC, et al. (2000) Resveratrol acts as a mixed agonist/antagonist for estrogen receptors α and β. Endocrinology 141, 36573667.
23 Inoue, H, Jiang, XF, Katayama, T, et al. (2003) Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor α in mice. Neurosci Lett 352, 203206.
24 Wood, JG, Rogina, B, Lavu, S, et al. (2004) Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430, 686689.
25 Jang, M, Cai, L, Udeani, GO, et al. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218220.
26 Harikumar, KB & Aggarwal, BB (2008) Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 7, 10201035.
27 MacRitchie, AN, Jun, SS, Chen, Z, et al. (1997) Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium. Circ Res 81, 355362.
28 Klinge, CM, Blankenship, KA, Risinger, KE, et al. (2005) Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors α and β in endothelial cells. J Biol Chem 280, 74607468.
29 Goya, K, Sumitani, S, Xu, X, et al. (2004) Peroxisome proliferator-activated receptor α agonists increase nitric oxide synthase expression in vascular endothelial cells. Arterioscler Thromb Vasc Biol 24, 658663.
30 Xu, J, Xie, Z, Reece, R, et al. (2006) Uncoupling of endothelial nitric oxide synthase by hypochlorous acid: role of NAD(P)H oxidase-derived superoxide and peroxynitrite. Arterioscler Thromb Vasc Biol 26, 26882695.

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed